1-13 of 13
transplantation, homologous
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nonmyeloablative allogeneic transplantation achieves clinical and molecular remission in cutaneous T-cell lymphoma

Clinical Trials & Observations
Wen-Kai Weng, Sally Arai, Andrew Rezvani, Laura Johnston, Robert Lowsky, David Miklos, Judith Shizuru, Lori Muffly, Everett Meyer, Robert S. Negrin, Erica Wang, Timothy Almazan, Lynn Million, Michael Khodadoust, Shufeng Li, Richard T. Hoppe, Youn H. Kim
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4474–4482.
https://doi.org/10.1182/bloodadvances.2020001627
Published: 2020
Journal Articles

Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation

Juliane Grimm, Madlen Jentzsch, Marius Bill, Karoline Goldmann, Julia Schulz, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3864–3874.
https://doi.org/10.1182/bloodadvances.2020001904
Published: 2020
Includes: Supplemental data
Journal Articles

Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results

Clinical Trials & Observations
Claude Gardin, Cécile Pautas, Elise Fournier, Raphaël Itzykson, Emilie Lemasle, Jean-Henri Bourhis, Lionel Adès, Jean-Pierre Marolleau, Jean-Valère Malfuson, Lauris Gastaud, Emmanuel Raffoux, Juliette Lambert, Thorsten Braun, Xavier Thomas, Sylvain Chantepie, Thomas Cluzeau, Stéphane de Botton, Céline Berthon, Nicolas Boissel, Nicolas Duployez, Christine Terré, Régis Peffault de Latour, Mauricette Michallet, Karine Celli-Lebras, Claude Preudhomme, Hervé Dombret
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1942–1949.
https://doi.org/10.1182/bloodadvances.2019001349
Published: 2020
Includes: Supplemental data
Journal Articles

Investigation of donor KIR content and matching in children undergoing hematopoietic cell transplantation for acute leukemia

Clinical Trials & Observations
Michael R. Verneris, Jeffrey S. Miller, Katherine C. Hsu, Tao Wang, Jennifer A. Sees, Sophie Paczesny, Hemalatha Rangarajan, Dean A. Lee, Stephen R. Spellman, Stephanie J. Lee
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1350–1356.
https://doi.org/10.1182/bloodadvances.2019001284
Published: 2020
Journal Articles

Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation

Clinical Trials & Observations
Yasuyuki Arai, Tadakazu Kondo, Kyoko Fuse, Yasuhiko Shibasaki, Masayoshi Masuko, Junichi Sugita, Takanori Teshima, Naoyuki Uchida, Takahiro Fukuda, Kazuhiko Kakihana, Yukiyasu Ozawa, Tetsuya Eto, Masatsugu Tanaka, Kazuhiro Ikegame, Takehiko Mori, Koji Iwato, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta
Journal: Blood Advances
Blood Adv (2019) 3 (22): 3626–3634.
https://doi.org/10.1182/bloodadvances.2019000934
Published: 2019
Includes: Supplemental data
Journal Articles

Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort

Clinical Trials & Observations
Michael A. Spinner, Vanessa E. Kennedy, John S. Tamaresis, Philip W. Lavori, Sally Arai, Laura J. Johnston, Everett H. Meyer, David B. Miklos, Lori S. Muffly, Robert S. Negrin, Andrew R. Rezvani, Judith A. Shizuru, Wen-Kai Weng, Richard T. Hoppe, Samuel Strober, Robert Lowsky
Journal: Blood Advances
Blood Adv (2019) 3 (16): 2454–2464.
https://doi.org/10.1182/bloodadvances.2019000297
Published: 2019
Includes: Supplemental data
Journal Articles

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Laura K. Schoch, Kenneth R. Cooke, Nina D. Wagner-Johnston, Ivana Gojo, Lode J. Swinnen, Philip Imus, Ephraim J. Fuchs, Mark Levis, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2226–2229.
https://doi.org/10.1182/bloodadvances.2018019208
Published: 2018
Journal Articles

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

Clinical Trials & Observations
Brian Ball, Rami S. Komrokji, Lionel Adès, Mikkael A. Sekeres, Amy E. DeZern, Lisa Pleyer, Norbert Vey, Antonio Almeida, Ulrich Germing, Thomas Cluzeau, Uwe Platzbecker, Steven D. Gore, Pierre Fenaux, Thomas Prebet
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2063–2071.
https://doi.org/10.1182/bloodadvances.2018015529
Published: 2018
Includes: Supplemental data
Journal Articles

Ten-year outcome of patients with acute myeloid leukemia not treated with allogeneic transplantation in first complete remission

Clinical Trials & Observations
Sumithira Vasu, Jessica Kohlschmidt, Krzysztof Mrózek, Ann-Kathrin Eisfeld, Deedra Nicolet, Lisa J. Sterling, Heiko Becker, Klaus H. Metzeler, Dimitrios Papaioannou, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Maria R. Baer, Gail J. Roboz, Richard M. Stone, John C. Byrd, Andrew J. Carroll, Clara D. Bloomfield
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1645–1650.
https://doi.org/10.1182/bloodadvances.2017015222
Published: 2018
Includes: Supplemental data
Journal Articles

Allogeneic transplantation using TLI-ATG conditioning for Hodgkin lymphoma after failure of autologous transplantation

Clinical Trials & Observations
Michael A. Spinner, Ranjana H. Advani, Richard T. Hoppe, Robert Lowsky, Lori S. Muffly
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1547–1550.
https://doi.org/10.1182/bloodadvances.2018021071
Published: 2018
Journal Articles

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis

Clinical Trials & Observations
Nirav N. Shah, Kwang Woo Ahn, Carlos Litovich, Timothy S. Fenske, Sairah Ahmed, Minoo Battiwalla, Nelli Bejanyan, Parastoo B. Dahi, Javier Bolaños-Meade, Andy I. Chen, Stefan O. Ciurea, Veronika Bachanova, Zachariah DeFilipp, Narendranath Epperla, Nosha Farhadfar, Alex F. Herrera, Bradley M. Haverkos, Leona Holmberg, Nasheed M. Hossain, Mohamed A. Kharfan-Dabaja, Vaishalee P. Kenkre, Hillard M. Lazarus, Hemant S. Murthy, Taiga Nishihori, Andrew R. Rezvani, Anita D’Souza, Bipin N. Savani, Matthew L. Ulrickson, Edmund K. Waller, Anna Sureda, Sonali M. Smith, Mehdi Hamadani
Journal: Blood Advances
Blood Adv (2018) 2 (8): 933–940.
https://doi.org/10.1182/bloodadvances.2018018531
Published: 2018
Includes: Supplemental data
Journal Articles

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD

Nelli Bejanyan, Claudio G. Brunstein, Qing Cao, Aleksandr Lazaryan, Xianghua Luo, Julie Curtsinger, Rohtesh S. Mehta, Erica Warlick, Sarah A. Cooley, Bruce R. Blazar, Jeffrey S. Miller, Daniel Weisdorf, John E. Wagner, Michael R. Verneris
Journal: Blood Advances
Blood Adv (2018) 2 (8): 909–922.
https://doi.org/10.1182/bloodadvances.2017014464
Published: 2018
Includes: Supplemental data
Journal Articles

Choosing for whom to recommend allogeneic transplantation for acute myeloid leukemia in CR1: a continued, complicated conversation

Clinical Trials & Observations
Kamal N. Menghrajani, Martin S. Tallman
Journal: Blood Advances
Blood Adv (2018) 2 (2): 164.
https://doi.org/10.1182/bloodadvances.2017007674
Published: 2018
Includes: Supplemental data